<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Center for Bioethics and Humanities

Drug Delivery Through Placenta and Then Breastmilk for Fetal Cystic Fibrosis: Collateral Benefit and Social Good Do Not Make an Acceptable Risk: Benefit Ratio

Default sub title

minute read

by The American Journal of Bioethics | September 18, 2025
placeholder
Gianna Morales co-authors study on ethical risks of fetal cystic fibrosis drug delivery via placenta and breastmilk, examining risk-benefit limits. 

Topics: Press Coverage

Related Articles

Programs

Graduate Certificate in Bioethics and Humanities in Health

Health Humanities and Arts Research Collaboration

Holocaust, Genocide and Contemporary Bioethics

Center Resources

Chancellor's Vision on an Ethical Culture

Colorado Area Health Education Center (AHEC)

Join Our Email Community

Map and Directions

Donate

Arts and Humanities Fund

Support Our Mission

© 2025  The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.